Pitfalls in the measurement of skin autofluorescence to determine tissue advanced glycosylation content in haemodialysis patients

Nephrology

Volumn 18, Issue 10, 2013, Pages 671-675

  Chaudhri, Saurabh ^a   Fan, Stanley ^b   Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

advanced glycosylation end product; ethnicity; haemodialysis; skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BRACHIAL ARTERY; DIABETES MELLITUS; FEMALE; FOREARM; GLYCOSYLATION; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RADIAL ARTERY; SKIN AUTOFLUORESENCE; SKIN PIGMENTATION;

ADVANCED GLYCOSYLATION END PRODUCT; ETHNICITY; HAEMODIALYSIS; SKIN AUTOFLUORESCENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CATHETERIZATION, CENTRAL VENOUS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOREARM; GLYCOSYLATION END PRODUCTS, ADVANCED; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SKIN; SKIN PIGMENTATION; SPECTROMETRY, FLUORESCENCE; WEST INDIES;

EID: 84884897107     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12118     Document Type: Article

References (24)

1. Maillard LC,. The action of amino acids on sugar; The formation of melanoidin by a methodic route. Cr. Hebd. Acad. Sci. 1912; 154: 66-68.
2. Bucala R, Cerami A,. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv. Pharmacol. 1992; 23: 1-34.
3. Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study. Diabetes Care 2011; 34: 442-447.
4. Henle T, Deppisch R, Beck W, Hergesell O, Hansch GM, Ritz E,. Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol. Dial. Transplant. 1999; 14: 1968-1975.
5. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uraemia. Kidney Int. 1996; 49: 1304-1313.
6. Lin CL, Huang CC, Yu CC, Yang HY, Chuang FR, Yang C,. Reduction of advanced glycation end product levels by on-line haemodiafiltration in long-term haemodialysis patients. Am. J. Kidney Dis. 2003; 42: 524-531.
7. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324-1330.
8. Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in haemodialysis patients. J. Am. Soc. Nephrol. 2005; 16: 3687-3693.
9. Meerwaldt R, Zeebregts CJ, Navis G, Hillebrands JL, Lefrandt JD, Smit AJ,. Accumulation of advanced glycation end dproducts and chronic complications in ESRD treated by dialysis. Am. J. Kidney Dis. 2009; 53: 138-150.
10. Na R, Stender IM, Henriksen M, Wulf HC,. Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J. Invest. Dermatol. 2001; 116: 536-540.
11. Hartog JW, de Vries AP, Lutgers HL, et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann. N. Y. Acad. Sci. 2005; 1043: 299-307.
12. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R,. Reference values of skin autofluorescence. Diabetes Technol. Ther. 2010; 12 (5): 399-403.
13. Vernon K, Peasegood J, Riddell A, Davenport A,. Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin. Pract. 2010; 117: c403-408.
14. Davenport A,. Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 2009; 14: 455-461.
15. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW,. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin. J. Am. Soc. Nephrol. 2011; 6 (10): 2356-2363.
16. Blackwell J, Katika KM, Pilon L, Dipple KM, Levin SR, Nouvong A,. In vivo time-resolved autofluorescence measurements to test for glycation of human skin. J. Biomed. Opt. 2008; 13: 014004.
17. Oleniuc M, Schiller A, Secara I, et al. Evaluation of advanced glycation end products accumulation, using skin autofluorescence, in CKD and dialysis patients. Int. Urol. Nephrol. 2012; 44: 1441-1449.
18. Sandby-Møller J, Poulsen T, Wulf HC,. Influence of epidermal thickness, pigmentation and redness on skin autofluorescence. Photochem. Photobiol. 2003; 77: 616-620.
19. Gerrits EG, Lutgers HL, Smeets GH, et al. Skin autofluorescence: A pronounced marker of mortality in hemodialysis patients. Nephron Extra 2012; 2: 184-191.
20. Momma H, Niu K, Kobayashi Y, et al. Skin advanced glycation end product accumulation and muscle strength among adult men. Eur. J. Appl. Physiol. 2011; 111: 1545-1552.
21. Bemelmans RH, Boerma EC, Barendregt J, Ince C, Rommes JH, Spronk PE,. Changes in the volume status of haemodialysis patients are reflected in sublingual microvascular perfusion. Nephrol. Dial. Transplant. 2009; 24 (11): 3487-3492.
22. Booth J, Pinney J, Davenport A,. The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance. Nephrol. Dial. Transplant. 2011; 26: 227-231.
23. Kumar S, Khosravi M, Massart A, Potluri M, Davenport A,. Changes in upper limb extracellular water content ?during haemodialysis measured by multi-frequency bioimpedance. Int. J. Artif. Organs 2013; 36: 203-207.
24. Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ,. Dermal Factors influencing measurement of skin autofluorescence. Diabetes Technol. Ther. 2011; 13: 165-170.